We are live on
!
Find out more
SHI
SV Health Investors Portfolio holdings
AUM
$32.3M
1-Year Est. Return
20.15%
This Fund
S&P 500
This Quarter
Est. Return
+22.39%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$267M
AUM Growth
+$59.4M
(+29%)
Cap. Flow
+$22.6M
Cap. Flow
% of AUM
8.47%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdaptHealth
AHCO
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Well
AMWL
|
+$42.1M |
| 2 |
KALV
KalVista Pharmaceuticals
KALV
|
+$25.7M |
| 3 |
TECX
Tectonic Therapeutic
TECX
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SAM
FCOMV
LUGPSI
VCA
PGM
ACM
KCM
KXA
SV Health Investors's Q1 2021 Portfolio in Review
As of Q1 2021, SV Health Investors held 10 positions worth $267M, up 29% from $208M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
SV Health Investors deployed $22.6M of net new capital in Q1 2021, opening 1 new position. Its largest new stake was AdaptHealth: 2,911,677 shares worth $107M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
On the sell side, the largest reduction was Tectonic Therapeutic, an estimated $12.4M trimmed.
- SV Health Investors's largest Q1 2021 buy was AdaptHealth: 2,911,677 shares worth $107M.
- SV Health Investors's biggest Q1 2021 reduction was Tectonic Therapeutic, cutting an estimated $12.4M.
- SV Health Investors fully exited American Well in Q1 2021, selling an estimated $42.1M.
- SV Health Investors's ten largest holdings make up 100% of its $267M portfolio in Q1 2021.
- SV Health Investors opened 1 new position and closed 2 in Q1 2021.
- SV Health Investors's portfolio value rose 29% quarter-over-quarter to $267M.
Based on SV Health Investors's 13F filing for Q1 2021, filed 17 May 2021.